13 results for "David Shitrit"
Showing 1–13 · 0.40 seconds · RSS
-
Journal Article
TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a chronic and ultimately fatal disease characterized by a progressive decline in lung function. Fibrotic diseases, such as IPF, are characterized by uncontrolled activation of fibroblasts. Since the microenvironment is known to affect cell…
-
Journal Article
Aspirin use is safe in patients undergoing transbronchial lung cryobiopsy
Background: Aspirin has been shown to be safe for patients undergoing certain diagnostic bronchoscopy procedures, such as transbronchial biopsies and endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration. However, there are no studies documenting the safety of aspirin in patients…
-
Journal Article
Fibroblast paracrine TNF-α signaling elevates integrin A5 expression in idiopathic pulmonary fibrosis (IPF)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis. Inflammatory cytokines play a significant role in IPF pathology. However, the fibroblast itself is also believed to be the primary effector in IPF. We hypothesized that the fibroblasts…
-
Journal Article
MiR-608 overexpression in idiopathic pulmonary fibrosis (IPF)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease that causes scarring of the lungs. The disease is associated with the usual interstitial pneumonia pattern, which was not yet fully recapitulated by an animal model. Therefore, the disease is considered ‘human…
-
Journal Article
Successful lung transplantation for talcosis secondary to intravenous abuse of oral drug
Dekel Shlomi1, David Shitrit1, Daniele Bendayan1, Gidon Sahar2, Yitshak Shechtman3, Mordechai R Kramer11Pulmonary Institute, Departments of 2Cardiothoracic Surgery and 3Pathology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv…
-
Journal Article
Transbronchial cryobiopsy is safe for patients with echocardiographic evidence of pulmonary hypertension: a blinded prospective cohort study
IntroductionBleeding is the most concerning complication of transbronchial lung cryobiopsy (TBCB). Pulmonary hypertension (PH) is frequently treated as a relative contraindication to bronchoscopic biopsy because of presumed excess bleeding risk, yet TBCB specific data is limited.MethodsWe conducted…
-
Journal Article
Integrin alpha-5 silencing leads to myofibroblastic differentiation in IPF-derived human lung fibroblasts
Background and objective: The term ‘fibroblast’ covers a heterogeneous cell population in idiopathic pulmonary fibrosis (IPF). The fibroblasts are considered as main effector cells, because they promote disease progression by releasing exaggerated amounts of extracellular matrix proteins and…
-
Journal Article
Peripheral blood telomere alterations in ground glass opacity (GGO) lesions may suggest malignancy
A ground glass opacity (GGO) lung lesion may represent early stage adenocarcinoma, which has an excellent prognosis upon prompt surgical resection. However, GGO lesions have broad differential diagnoses, including both benign and malignant lesions. Our objective was to study telomere length and…
-
Journal Article Full text
Interstitial Lung Diseases in Israel: Large Variability in Close Geographic Proximity
Background: There have been no previous comprehensive reports on interstitial lung diseases (ILD) in Israeli population, that may have unique epidemiological features. We aimed to explore ILD in Israel, with an emphasis on disparities between different regions of the country. Methods: The study…
-
Journal Article
Galectin-3 levels are elevated following nintedanib treatment
Background and Aims: Idiopathic pulmonary fibrosis (IPF) is a common and severe form of pulmonary fibrosis. Nintedanib, a triple angiokinase inhibitor, is approved for treating IPF. Galectin 3 (Gal-3) activates a variety of profibrotic processes. Currently, the Gal-3 inhibitor TD139 is being tested…
-
Journal Article
Dynamics of interstitial lung disease following immunosuppressive treatment differ between antisynthetase syndrome and systemic sclerosis
Background: Interstitial lung disease (ILD) is the main clinical feature of antisynthetase syndrome (ASS). In the absence of randomized controlled trials to guide therapy, treatment strategies are often extrapolated from other diseases, mainly systemic sclerosis (SSc). Objectives: Our aim was to…
-
Journal Article
Patterns of bronchoalveolar lavage in fibrotic and non-fibrotic interstitial lung diseases – a multicenter analysis
Abstract Background Bronchoalveolar lavage (BAL) cellular analysis is recommended as part of the diagnostic workup of interstitial lung diseases (ILD) when diagnosis is unclear. In recent years, ILD have been classified based on the presence or absence of fibrosis. The objective of this study was…
-
Journal Article Full text
Real-Life Diagnostic Performance of the Hypersensitivity Pneumonitis Guidelines: A Multicenter Cohort Study
Hypersensitivity pneumonitis (HP) is a heterogeneous interstitial lung disease (ILD) that may be difficult to confidently diagnose. Recently, the 2020 ATS/JRS/ALAT HP diagnostic guidelines were published, yet data validating their performance in real-life settings are scarce. We aimed to assess the…